Literature DB >> 18364356

Requirement of inositol 1,4,5-trisphosphate receptors for tumor-mediated lymphocyte apoptosis.

Camia Steinmann1, Megan L Landsverk, José M Barral, Darren Boehning.   

Abstract

Tumor cells strategically down-regulate Fas receptor expression to evade immune attack and up-regulate expression of Fas ligand to promote apoptosis of infiltrating T lymphocytes. Many pathways leading to apoptotic cell death require calcium release from inositol 1,4,5-trisphosphate receptors (IP3Rs). Here, we show that Fas-dependent killing of Jurkat T lymphoma cells by SW620 colon cancer cells requires calcium release from IP3R. General suppression of IP3R signaling significantly reduced SW620-mediated Jurkat cell apoptosis. Significantly, a specific inhibitor of apoptotic calcium release from IP3R strongly blocked lymphocyte apoptosis. Thus, selective pharmacological targeting of apoptotic calcium release from IP3R may enhance tumor cell immunogenicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18364356      PMCID: PMC2376216          DOI: 10.1074/jbc.C800029200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  A peptide inhibitor of cytochrome c/inositol 1,4,5-trisphosphate receptor binding blocks intrinsic and extrinsic cell death pathways.

Authors:  Darren Boehning; Damian B van Rossum; Randen L Patterson; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

2.  Fas ligand promotes tumor immune evasion of colon cancer in vivo.

Authors:  Aideen E Ryan; Fergus Shanahan; Joe O'Connell; Aileen M Houston
Journal:  Cell Cycle       Date:  2006-02-14       Impact factor: 4.534

3.  Immune privilege or inflammation? Insights into the Fas ligand enigma.

Authors:  J O'Connell; A Houston; M W Bennett; G C O'Sullivan; F Shanahan
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

4.  Fas ligand upregulation is an early event in colonic carcinogenesis.

Authors:  M W Bennett; J O'Connell; A Houston; J Kelly; G C O'Sullivan; J K Collins; F Shanahan
Journal:  J Clin Pathol       Date:  2001-08       Impact factor: 3.411

5.  Hydroxylated xestospongins block inositol-1,4,5-trisphosphate-induced Ca2+ release and sensitize Ca2+-induced Ca2+ release mediated by ryanodine receptors.

Authors:  Tram Anh Ta; Wei Feng; Tadeusz F Molinski; Isaac N Pessah
Journal:  Mol Pharmacol       Date:  2005-10-25       Impact factor: 4.436

6.  Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.

Authors:  Aideen E Ryan; Fergus Shanahan; Joe O'Connell; Aileen M Houston
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

7.  Fas and Fas ligand as prognostic factors in human breast carcinoma.

Authors:  Marek Bebenek; Danuta Duś; Joanna Koźlak
Journal:  Med Sci Monit       Date:  2006-11

Review 8.  The biological role of the Fas/FasL system during tumor formation and progression.

Authors:  Ernst Reichmann
Journal:  Semin Cancer Biol       Date:  2002-08       Impact factor: 15.707

9.  Requirement of biphasic calcium release from the endoplasmic reticulum for Fas-mediated apoptosis.

Authors:  Ann L Wozniak; Xinmin Wang; Emily S Stieren; Shelby G Scarbrough; Cornelis J Elferink; Darren Boehning
Journal:  J Cell Biol       Date:  2006-11-27       Impact factor: 10.539

10.  Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression.

Authors:  K Yamana; V Bilim; N Hara; T Kasahara; T Itoi; R Maruyama; T Nishiyama; K Takahashi; Y Tomita
Journal:  Br J Cancer       Date:  2005-09-05       Impact factor: 7.640

View more
  8 in total

Review 1.  Ca(2+) transfer from the ER to mitochondria: when, how and why.

Authors:  Rosario Rizzuto; Saverio Marchi; Massimo Bonora; Paola Aguiari; Angela Bononi; Diego De Stefani; Carlotta Giorgi; Sara Leo; Alessandro Rimessi; Roberta Siviero; Erika Zecchini; Paolo Pinton
Journal:  Biochim Biophys Acta       Date:  2009-03-31

Review 2.  Oxidative protein folding in the endoplasmic reticulum: tight links to the mitochondria-associated membrane (MAM).

Authors:  Thomas Simmen; Emily M Lynes; Kevin Gesson; Gary Thomas
Journal:  Biochim Biophys Acta       Date:  2010-04-27

3.  IP3 Receptor Biology and Endoplasmic Reticulum Calcium Dynamics in Cancer.

Authors:  Jan B Parys; Geert Bultynck; Tim Vervliet
Journal:  Prog Mol Subcell Biol       Date:  2021

4.  Functional osteoclast attachment requires inositol-1,4,5-trisphosphate receptor-associated cGMP-dependent kinase substrate.

Authors:  Beatrice B Yaroslavskiy; Irina Turkova; Yujuan Wang; Lisa J Robinson; Harry C Blair
Journal:  Lab Invest       Date:  2010-06-21       Impact factor: 5.662

5.  Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells.

Authors:  Mostafa A Borahay; Gokhan S Kilic; Chandrasekha Yallampalli; Russell R Snyder; Gary D V Hankins; Ayman Al-Hendy; Darren Boehning
Journal:  J Biol Chem       Date:  2014-10-30       Impact factor: 5.157

6.  Mitochondrial reactive oxygen species are activated by mGluR5 through IP3 and activate ERK and PKA to increase excitability of amygdala neurons and pain behavior.

Authors:  Zhen Li; Guangchen Ji; Volker Neugebauer
Journal:  J Neurosci       Date:  2011-01-19       Impact factor: 6.167

7.  Identification of functionally critical residues in the channel domain of inositol trisphosphate receptors.

Authors:  Cunnigaiper Bhanumathy; Paula C A da Fonseca; Edward P Morris; Suresh K Joseph
Journal:  J Biol Chem       Date:  2012-10-18       Impact factor: 5.157

Review 8.  Protein Lipidation As a Regulator of Apoptotic Calcium Release: Relevance to Cancer.

Authors:  Jessica J Chen; Darren Boehning
Journal:  Front Oncol       Date:  2017-06-29       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.